N-Nitroso Tadalafil
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Tadalafil is used to treat men who have erectile dysfunction (also called sexual impotence). Tadalafil belongs to a group of medicines called phosphodiesterase 5 (PDE5) inhibitors. These medicines prevent an enzyme called phosphodiesterase type-5 from working too quickly.Tadalafil Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Tadalafil or Tadalafil Nitroso Impurity 1 CAS NO:NA also known as N-Nitroso Tadalafil Impurity Chemically represented as (6R,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-7-nitroso-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione . Synchemia is the leading manufacturing and exporter of Tadalafil Nitroso Impurity 1 . We supply Tadalafil Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142627 |
| CAS No | NA |
| Mol.F. | C14H19ClN2O3 |
| Mol.Wt. | 298.8g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142628 |
| CAS No | NA |
| Mol.F. | C13H16Cl2N2O2 |
| Mol.Wt. | 303.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142629 |
| CAS No | NA |
| Mol.F. | C13H17ClN2O2 |
| Mol.Wt. | 268.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142630 |
| CAS No | NA |
| Mol.F. | C13H17BrN2O2 |
| Mol.Wt. | 313.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142631 |
| CAS No | NA |
| Mol.F. | C12H13ClN2O4S |
| Mol.Wt. | 316.8 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142632 |
| CAS No | NA |
| Mol.F. | C13H17ClN2O2 |
| Mol.Wt. | 268.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142633 |
| CAS No | NA |
| Mol.F. | C13H16Cl2N2O2 |
| Mol.Wt. | 303.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142634 |
| CAS No | NA |
| Mol.F. | C13H17ClN2O3 |
| Mol.Wt. | 284.74 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142635 |
| CAS No | NA |
| Mol.F. | C21H32N6O4 |
| Mol.Wt. | 432.53 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142636 |
| CAS No | NA |
| Mol.F. | C33H50N10O4 |
| Mol.Wt. | 650.83 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142637 |
| CAS No | NA |
| Mol.F. | C34H51N7O6 |
| Mol.Wt. | 653.83 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142638 |
| CAS No | NA |
| Mol.F. | C9H12N2O3 |
| Mol.Wt. | 196.21 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142639 |
| CAS No | NA |
| Mol.F. | C11H10N4O3 |
| Mol.Wt. | 246.23 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142640 |
| CAS No | NA |
| Mol.F. | C25H40N6O4 |
| Mol.Wt. | 488.63 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142641 |
| CAS No | NA |
| Mol.F. | C23H36N6O4 |
| Mol.Wt. | 460.58 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N01426412 |
| CAS No | NA |
| Mol.F. | C13H14ClN5O4 |
| Mol.Wt. | 339.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |